SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Acquired by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. raised its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 131.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 25,460 shares of the exchange traded fund’s stock after acquiring an additional 14,449 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in SPDR S&P Biotech ETF were worth $2,273,000 as of its most recent filing with the SEC.

A number of other large investors have also recently made changes to their positions in XBI. Roundview Capital LLC boosted its position in shares of SPDR S&P Biotech ETF by 275.4% in the 1st quarter. Roundview Capital LLC now owns 7,599 shares of the exchange traded fund’s stock valued at $683,000 after purchasing an additional 5,575 shares during the period. U.S. Capital Wealth Advisors LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the 1st quarter valued at about $222,000. Synovus Financial Corp boosted its position in shares of SPDR S&P Biotech ETF by 559.1% in the 1st quarter. Synovus Financial Corp now owns 15,462 shares of the exchange traded fund’s stock valued at $1,390,000 after purchasing an additional 13,116 shares during the period. Vontobel Holding Ltd. boosted its position in shares of SPDR S&P Biotech ETF by 6.7% in the 1st quarter. Vontobel Holding Ltd. now owns 6,400 shares of the exchange traded fund’s stock valued at $575,000 after purchasing an additional 400 shares during the period. Finally, Sequoia Financial Advisors LLC boosted its position in shares of SPDR S&P Biotech ETF by 17.6% in the 1st quarter. Sequoia Financial Advisors LLC now owns 2,234 shares of the exchange traded fund’s stock valued at $201,000 after purchasing an additional 334 shares during the period.

SPDR S&P Biotech ETF Stock Down 0.8 %

XBI opened at $82.81 on Friday. The business has a 50 day moving average price of $93.52 and a two-hundred day moving average price of $84.21. The company has a market cap of $6.43 billion, a PE ratio of 11.47 and a beta of 1.08. SPDR S&P Biotech ETF has a 52 week low of $63.80 and a 52 week high of $103.52.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.